United Therapeutics Corporation (FRA:UTH)
Germany
· Delayed Price · Currency is EUR 415.40
+2.30 (0.56%)
At close: Dec 5, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Tyvaso Revenue | 1.83B | 1.62B |
Log In |
Log In |
Log In | Upgrade
|
| Remodulin Revenue | 533.30M | 538.10M |
Log In |
Log In |
Log In | Upgrade
|
| Orenitram Revenue | 483.50M | 434.30M |
Log In |
Log In |
Log In | Upgrade
|
| Unituxin Revenue | 232.00M | 238.70M |
Log In |
Log In |
Log In | Upgrade
|
| Adcirca Revenue | 26.90M | 23.80M |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Sales Revenue | 3.11B | 2.86B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 22.90M | 22.10M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 3.13B | 2.88B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| United States Revenue | 2.99B | 2.74B |
Log In |
Log In |
Log In | Upgrade
|
| Rest-of-World Revenue | 138.50M | 137.70M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 3.13B | 2.88B |
Log In |
Log In |
Log In | Upgrade
|
Gross Profit
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Tyvaso Gross Profit | 1.61B | 1.44B |
Log In |
Log In |
Log In | Upgrade
|
| Remodulin Gross Profit | 478.70M | 490.70M |
Log In |
Log In |
Log In | Upgrade
|
| Orenitram Gross Profit | 456.00M | 405.90M |
Log In |
Log In |
Log In | Upgrade
|
| Unituxin Gross Profit | 218.20M | 224.30M |
Log In |
Log In |
Log In | Upgrade
|
| Adcirca Gross Profit | 15.40M | 13.70M |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Sales Gross Profit | 2.78B | 2.57B |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Other) | -9.90M | -4.80M |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Total) | 2.77B | 2.57B |
Log In |
Log In |
Log In | Upgrade
|